Graphite Bio, Inc. Financials

Market Capitalization $None as of Jan. 11, 2021

Valuations Metrics as of May. 5, 2024

Trailing PE
Forward PE	-7.95
Price to Sales TTM	$
Price to Book MRQ	$0.14
Enterprise to Revenue
Enterprise to EBITDA	-0.02

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	0.00%
Operating Margin	0.00%
Return on Assets TTM	-17.99%
Return on Equity TTM	-51.95%

Income Statement

Revenue TTM	$0
Revenue per Share TTM	$
Quarterly Revenue Growth	%
Gross Profit TTM	$0
EBITDA	$-71,041,000
Net Income to Common TTM	$-124,651,000
Diluted EPS TTM	$-15.33
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	$184,259,008
Total Cash per Share MRQ	$22.15
Total Debt MRQ	$
Total Debt to Equity MRQ	0.20
Current Ratio MRQ	39.20
Book Value per Share MRQ	$22.15

Cash Flow

Operating Cash Flow TTM	$-90,007,000
Levered Free Cash Flow TTM	$-44,892,000

GRPH Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	58,236,900
Float Shares	2,382,638
Avg 10 Volume	184,381
Avg 30 Volume	None
Shares Short	100,577
Short Ratio	7.93
Short % of Shares	0.28%
% Held by Insiders	%
% Held by Institutions	%

Stock Price Summary

Beta	0.20
Fifty Two Week Low	$3.18
Fifty Two Week High	$29.82
Fifty Two Week Change	-36.52%
Day 50 MA	$21.30
Day 200 MA	$18.24

Dividends and Splits

Forward Annual Dividend Rate	$4.12
Forward Annual Dividend Yield	129.56%
Trailing Annual Dividend Rate	$1.03
Trailing Annual Dividend Yield	32.39%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2024-03-22
Last Split Factor
Last Split Date	2024-03-22